Assessment of malonyldialdehyde concentration as a product of lipid peroxidation and lipid metabolism in patients on chronic dialysis;Ocena stȩżenia malonylodialdehydu jako produktu peroksydacji lipidów a gospodarka lipidowa u chorych przewlekle dializowanych

Polski Merkuriusz Lekarski

Volumn 20, Issue 120, 2006, Pages 664-667

  Miler, Marlena ^a   Zamojska, Sylwia ^a   Fijałkowski, Paweł ^a   Łobos, Marek ^a   Paradowski, Marek T ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Arteriosclerosis; Chronic dialysis; Lipid metabolism; Lipid peroxidation; Malonyldialdehyde

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; PHOSPHOLIPID; TRIACYLGLYCEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LIPID METABOLISM; LIPID PEROXIDATION; OXIDATIVE STRESS; PROTEIN ANALYSIS; RISK ASSESSMENT; TREATMENT DURATION; BLOOD; CHRONIC KIDNEY FAILURE; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; RENAL REPLACEMENT THERAPY;

ADULT; AGED; CHOLESTEROL, LDL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; PHOSPHOLIPIDS; RENAL DIALYSIS; TRIGLYCERIDES;

EID: 33746134413     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Aymelek G., Mehmet N.: Lipid peroxidation and antioxidant systems in hemodialyzed patients. Nephrol. Dial. Transplant., 2002, 31(2), 88-96.
2. Cybulska B., Ceremużyński L., Hanzlik J. i wsp: Standardy Polskiego Towarzystwa Kardiologicznego. Kardiol. Pol., 1997, XLVI, 64
3. Durak I., Kacmaz M., Elgun S. i wsp.: Oxidative stress in patients with chronic renal failure: effects of hemodialysis. Med. Princ. Pract., 2004, 13(2), 84-7.
4. Hasselwander O., Young I.S: Oxidation of low - density lipoprotein and atherosclerosis in renal failure. Med. Hypotheses., 1997, 49, 389-395.
5. Hirayama A., Chie T., Nagase S., Ueda A., Gotoh M., Takomura K.: Hemodialysis does not influence the peroxidative state already present in uremia. Nephron, 2000, 86, 436-440.
6. Hiroshi M., Hidehiro M., Hiroyuki I.: Hemodialysis impairs endothelial function via oxidative stress. Circulation, 2000, 100, 92-102.
7. Jȩdryczko A., Grzeszczak W., Gorczyca E.: Nadtlenki lipidów i witamina E w osoczu i w lipoproteinach osocza krwi u chorych przewlekle dializowanych. Pol. Arch. Med. Wew., 1994, 92, 123-128.
8. Jung H.H., Choi D.H., Lee S.H.: Serum malondialdehyde and coronary artery disease in hemodialysis patients. Am. J. Nephrol., 2004, 25(5), 537-42.
9. Kinouchi M., Ono S., Nakajima T. i wsp: Serum lipid metabolism abnormalities and change in lipoprotein contents in patients with advanced-stage renal disease. Clin. Chim. Acta., 2001, 314(1-2), 27-37.
10. Kushiya F., Wada H., Sakakura M. i wsp.: Effects of lipid abnormalities on arteriosclerosis and hemostatic markers in patients under hemodialysis. Clin. Appl. Thromb. Hemost., 2003, 9(3), 203-10.
11. London G.M.: Cardiovascular risk in end-stage renal disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management. Nephrol. Dial. Transplant., 2000, 15 (supl 5), 52-8.
12. Morena M., Cristol J.P., Dantoine T. i wsp.: Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients. Nephrol. Dial. Transplant., 2000, 15(3), 389-95.
13. Mydlik M., Derzsiova K., Racz O.: Vitamin E-coated dialyzer and antioxidant defense parameters: three-month study. Semin. Nephrol., 2004, 24(5), 525-31.
14. Neuzil J., Weber C., Kontush A.: Role of vitamin E in atherogenesis: linking the chemical, biological and clinical aspects of disease. Atherosclerosis, 2001, 157, 257-83.
15. Samouilidou E., Grapsa E.: Effect of dialysis on plasma total antioxidant capacity and lipid peroxidation products in patients with end-stage renal failure. Blood Purif., 2003, 21(3), 2009-12.
16. Wiktorowicz B. A., Lorenc J.B., Chrzanowski W.: Lipid and lipoprotein disturbances in chronic renal failure. Przegl. Lek., 1996, 53, 76-79.
17. Young I.S., Trimble E.R.: Measurement of malondialdehyde in plasma byperformance liquid chromatography with fluorometric detection. Ann. Clin. Biochem., 1991, 28, 504-508.